Breaking News, Collaborations & Alliances

Foamix Earns $2.5M Bayer Milestone

License agreement includes foam vehicle for Azelaic Acid

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Foamix Pharmaceuticals has received a $2.5 million milestone payment under a license agreement with Bayer HealthCare. Foamix is entitled to royalties and further milestone payments under certain conditions. Terms of the agreement were not disclosed.   Under the agreement, Bayer has licensed a foam vehicle from Foamix for its compound azelaic acid. Azelaic Acid Foam 15% is currently in Phase III development for the treatment of Rosacea....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters